Bessemer Group Inc Neurocrine Biosciences Inc Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Bessemer Group Inc holds 21,766 shares of NBIX stock, worth $2.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,766

Previous 1,598 1262.08%

Holding current value

$2.95 Million

Previous $220,000 1039.55%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$114.58 - $153.15 $2.31 Million - $3.09 Million	20,168 Added 1262.08%	21,766 $2.51 Million
Q1 2024 May 13, 2024	SELL	$130.4 - $143.74 $1,043 - $1,149	-8 Reduced 0.5%	1,598 $221,000
Q4 2023 Feb 09, 2024	BUY	$106.07 - $132.76 $5,939 - $7,434	56 Added 3.61%	1,606 $212,000
Q3 2023 Nov 13, 2023	SELL	$94.02 - $117.1 $6,017 - $7,494	-64 Reduced 3.97%	1,550 $175,000
Q2 2023 Aug 10, 2023	BUY	$89.53 - $104.87 $11,638 - $13,633	130 Added 8.76%	1,614 $153,000
Q1 2023 May 10, 2023	BUY	$94.11 - $123.02 $107,473 - $140,488	1,142 Added 333.92%	1,484 $150,000
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $32,229 - $38,372	302 Added 755.0%	342 $42,000
Q3 2022 Nov 09, 2022	SELL	$92.03 - $107.81 $1,012 - $1,185	-11 Reduced 21.57%	40 $4,000
Q2 2022 Aug 10, 2022	SELL	$75.79 - $100.07 $12,353 - $16,311	-163 Reduced 76.17%	51 $5,000
Q1 2022 May 12, 2022	BUY	$72.45 - $94.81 $289 - $379	4 Added 1.9%	214 $20,000
Q4 2021 Jan 27, 2022	SELL	$79.65 - $106.22 $6,212 - $8,285	-78 Reduced 27.08%	210 $18,000
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $10,772 - $12,378	125 Added 76.69%	288 $28,000
Q2 2021 Aug 06, 2021	SELL	$89.43 - $102.27 $74,137 - $84,781	-829 Reduced 83.57%	163 $16,000
Q1 2021 May 13, 2021	BUY	$87.57 - $119.4 $86,869 - $118,444	992 New	992 $96,000
Q1 2019 May 13, 2019	SELL	$69.31 - $91.53 $10,743 - $14,187	-155 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$98.88 - $125.85 $15,326 - $19,506	155 New	155 $19,000

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Neurocrine Biosciences Inc Transaction History